Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Behrens

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Journal of the Pediatric Infectious Diseases Society|December 2, 2020
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Inflammatory Bowel Diseases|June 20, 2020
Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation GenesJudith R Kelsen, Noor Dawany, Maire A Conrad, et al.
Blood Advances|December 8, 2020
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentationsCaroline Diorio, Kevin O McNerney, Michele Lambert, et al.
Immunotherapy|June 18, 2025
Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summaryShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill childrenRobert B Lindell, Samir Sayed, Jose S Campos, et al.
Annals of the Rheumatic Diseases|July 24, 2023
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 9, 2024
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review StudyShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Pediatric Blood & Cancer|September 5, 2020
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndromeCaroline Diorio, Elizabeth M Anderson, Kevin O McNerney, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Journal of the Pediatric Infectious Diseases Society|December 2, 2020
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Inflammatory Bowel Diseases|June 20, 2020
Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation GenesJudith R Kelsen, Noor Dawany, Maire A Conrad, et al.
Blood Advances|December 8, 2020
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentationsCaroline Diorio, Kevin O McNerney, Michele Lambert, et al.
Immunotherapy|June 18, 2025
Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summaryShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill childrenRobert B Lindell, Samir Sayed, Jose S Campos, et al.
Annals of the Rheumatic Diseases|July 24, 2023
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 9, 2024
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review StudyShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Pediatric Blood & Cancer|September 5, 2020
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndromeCaroline Diorio, Elizabeth M Anderson, Kevin O McNerney, et al.
Pageof 15